People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Biotechnology, Software / Tech, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Magenta Therapeutics, Inc. | — | Biotechnology | Series C | $116.0M | $2.1B | 2016 |
| Tebra Technologies, Inc. | — | Software / Tech | Series B | $53.3M | $226.3M | 2012 |
| Obsidian Therapeutics, Inc. | — | Biotechnology | Series B | $32.4M | $1.3B | 2017 |
| PatientPop, Inc. | — | Other | Series A | $25.9M | $227.0M | 2018 |
| Marqeta, Inc. | — | Other Technology | Series B | $24.1M | $481.9M | 2011 |
JASON GARDNER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JASON GARDNER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Luke Kervin | 2 | 3 |
| Peter Barrett | 1 | 18 |
| Bruce Booth | 1 | 12 |
| Scott Maxwell | 1 | 11 |
| Adam Marcus | 1 | 9 |
| John Davis | 1 | 7 |
| David Neafus | 1 | 7 |
| Alexis Borisy | 1 | 6 |
| Michael Gilman | 1 | 6 |
| Blake Byers | 1 | 5 |
| BILL CONROY | 1 | 4 |
| Thomas Daniel | 1 | 4 |
| Patrick Mathieson | 1 | 4 |
| Karen Hong | 1 | 4 |
| Kenneth Fox | 1 | 3 |
| Todd Cozzens | 1 | 3 |
| Rob Reid | 1 | 3 |
| Travis Kalanick | 1 | 3 |
| Travis Schneider | 1 | 3 |
| Jeffrey Albers | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.